Biobank Registry for Bile Duct and Pancreas Diseases
Part of Digestive system clinical trials.
This trial is building a registry (a collection of samples and health information) for people with bile duct or pancreas diseases. By joining, you help researchers study these conditions to improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are willing to sign an informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry that collects information from people who have a pancreatic disease. It may help doctors better understand different pancreatic conditions and improve future care.
This study collects health information and tissue samples from people with pancreatic cancer or other pancreatic conditions. Your participation may help researchers better understand these diseases and improve future care.
This study collects health information and samples from people with chronic pancreatitis over time. It aims to better understand the disease and improve care for future patients.
This study is collecting medical information and blood samples from people with bile duct or gallbladder tumors to build a database that can help doctors better understand these conditions and improve future treatments.
This trial is a registry that collects information about adults who are having an ERCP procedure at the study site. It may help researchers better understand outcomes and improve care by tracking real-world results and possibly running smaller future studies.
This is a “registry” study that collects health information from adults with pancreatic ductal adenocarcinoma before starting treatment. It may help researchers better understand the disease and how patients are managed in real life.
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.